Literature DB >> 12538998

Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease.

Antonio Maria Calafiore1, Michele Di Mauro, Gabriele Di Giammarco, Marco Contini, Giuseppe Vitolla, Angela Lorena Iacò, Carlo Canosa, Stefano D'Alessandro.   

Abstract

OBJECTIVE: Diabetes has not yet been investigated as a risk factor for early and late cardiac-related death.
METHODS: Patients operated on from January 1988 to December 1999 were considered; 767 were diabetic (group D) and 2593 were nondiabetic (group ND). Patients with preoperative hemodynamic deterioration were excluded. Early (30-day) mortality (any causes and cardiac causes) was evaluated with univariate analysis and stepwise logistic regression. Ten-year actuarial freedom from death of any cause and cardiac death was also assessed with univariate and Cox analyses.
RESULTS: Early mortality was 2.2% (group D, 3.3%; group ND, 1.9%; P =.023). Early cardiac mortality was 1.3% (group D, 2.2%; group ND, 1.1%; P =.0016). Diabetes was an independent risk factor only for cardiac death and not for death of any cause. Five-year survival was 93.5% +/- 0.5% (group D, 92.5% +/- 1.1%; group ND, 93.9% +/- 0.6%; P =.0304). Diabetes was not an independent risk factor. Five-year freedom for cardiac death was 96.3% +/- 0.4% (group D, 94.9% +/- 0.9%; group ND, 96.6% +/- 0.4%; P =.0155). Diabetes was an independent risk factor. However, if only the patients who survived the first 30 days are considered, diabetes disappears as a risk factor (5-year freedom for cardiac death, 97.8% +/- 0.3%; group D, 97.3% +/- 0.8%; group ND, 97.9% +/- 0.4%; P = 0.2389).
CONCLUSIONS: Diabetes is an independent risk factor for early cardiac death only. Long-term survival in patients who survive the first 30 days is not statistically significantly different for diabetic and nondiabetic patients. In fact, the rates appear very similar.

Entities:  

Mesh:

Year:  2003        PMID: 12538998     DOI: 10.1067/mtc.2003.73

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  18 in total

1.  Coronary revascularization in diabetic patients: Current state of evidence.

Authors:  Mukesh Singh; Rohit Arora; Vamsi Kodumuri; Sandeep Khosla; Evyan Jawad
Journal:  Exp Clin Cardiol       Date:  2011

2.  'FREEDOM' trial: have the interventional cardiologists lost their freedom?

Authors:  Pankaj Jariwala; Sarat Chandra
Journal:  Indian Heart J       Date:  2013 Jan-Feb

3.  Estimated glucose disposal rate and long-term survival in type 2 diabetes after coronary artery bypass grafting.

Authors:  Thomas Nyström; Martin J Holzmann; Björn Eliasson; Ann-Marie Svensson; Jeanette Kuhl; Ulrik Sartipy
Journal:  Heart Vessels       Date:  2016-07-11       Impact factor: 2.037

4.  Diabetes and Cardioplegia.

Authors:  Brittany A Potz; Laura A Scrimgeour; Jun Feng; Frank W Sellke
Journal:  J Nat Sci       Date:  2017-06

5.  Preoperative hemoglobin A1c predicts atrial fibrillation after off-pump coronary bypass surgery.

Authors:  Takeshi Kinoshita; Tohru Asai; Tomoaki Suzuki; Atsushi Kambara; Keiji Matsubayashi
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

Review 6.  Metformin therapy in diabetes: the role of cardioprotection.

Authors:  Saloua El Messaoudi; Gerard A Rongen; Niels P Riksen
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

Review 7.  Microvascular dysfunction in patients with diabetes after cardioplegic arrest and cardiopulmonary bypass.

Authors:  Jun Feng; Frank Sellke
Journal:  Curr Opin Cardiol       Date:  2016-11       Impact factor: 2.161

8.  Glycemic Control in Coronary Revascularization.

Authors:  Francisco Ujueta; Ephraim N Weiss; Steven P Sedlis; Binita Shah
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-02

9.  Improving long term outcome for diabetic patients undergoing surgical revascularization by use of the radial artery conduit: a propensity matched study.

Authors:  Darryl M Hoffman; Kamellia R Dimitrova; Helbert Decastro; Patricia Friedmann; Charles M Geller; Wilson Ko; Robert F Tranbaugh
Journal:  J Cardiothorac Surg       Date:  2013-02-19       Impact factor: 1.637

10.  N-acetylcysteine and allopurinol confer synergy in attenuating myocardial ischemia injury via restoring HIF-1α/HO-1 signaling in diabetic rats.

Authors:  Xiaowen Mao; Tingting Wang; Yanan Liu; Michael G Irwin; Jing-song Ou; Xiao-long Liao; Xia Gao; Yuan Xu; Kwok F J Ng; Paul M Vanhoutte; Zhengyuan Xia
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.